To verify whether the core targets identified by RNA-seq play important roles in SGD treatment of OA, the mRNA expression levels of Il-17RB, Il-23R and GDF5 were measured by qRT-PCR. The gene discussed is IL17RB; the disease is specific granule deficiency.